All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of ...

Moderna plans to advance research on the mRNA vaccine into a phase 3 trial after receiving positive ... is a broad term that ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Sec. Mike Naig says the U.S. government is using what he describes as a three-legged stool approach to address the virus in ...

Health authorities need to be concerned about bird flu, but the risk to the public is low. You’re reading The Checkup With Dr ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

People who work with livestock are at the greatest risk of bird flu. To stop the disease's spread, it's critical that they participate in testing programs and wear masks and gloves when advised. “For ...

The H5N1 detection in a human is the UK’s first since 2023 when surveillance detected infections in poultry workers.